2021
Guillain-Barré Syndrome as a Complication of COVID-19
Zubair AS, Zubair AS, Desai K, Abulaban A, Roy B. Guillain-Barré Syndrome as a Complication of COVID-19. Cureus 2021, 13: e12695. PMID: 33614303, PMCID: PMC7883582, DOI: 10.7759/cureus.12695.Peer-Reviewed Case Reports and Technical NotesGuillain-Barre syndromeCases of GBSInitial COVID-19 infectionCOVID-19Multiple neurological complicationsIntravenous immunoglobulin therapyNerve conduction studiesCerebrospinal fluid analysisGuillain-Barré syndromeCOVID-19 infectionCoronavirus disease 2019Immunoglobulin therapyNeurological complicationsClinical suspicionSymptom onsetGBS casesIll patientsConduction studiesDisease 2019Correct diagnosisFluid analysisLonger durationComplicationsSyndromeInfection
2020
Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
Kovvuru S, Nalleballe K, Onteddu SR, Sharma R, Jasti M, Kapoor N, Veerapaneni K, Yadala S, Dandu V, Archer R, Nowak RJ, Roy B. Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic. Journal Of The Neurological Sciences 2020, 420: 117230. PMID: 33256952, PMCID: PMC7837234, DOI: 10.1016/j.jns.2020.117230.Peer-Reviewed Original ResearchConceptsAutoimmune neuromuscular disorderImmunosuppressive therapyMultiple sclerosisChronic autoimmune neuromuscular disorderNeuromuscular disordersCOVID-19Electronic medical record dataAutoimmune neurological disordersRisk of hospitalizationOverall infection riskMedical record dataRegistry-based dataCorona Virus Disease 2019Expert opinion guidelinesCOVID-19 databaseClinical research platformImmunosuppressed patientsImmunotherapy regimensAdditional physiciansDisease 2019Diseases-10International ClassificationPatientsNeurological disordersHospitalization